Medical Marijuana and Hemp News
Medical Marijuana and Hemp News
Medical Cannabis and Mental Health: Clarifying Research Gaps and the Call for Rescheduling
A recent Lancet Psychiatry review on medical cannabis for mental health highlights a scarcity of evidence, not ineffectiveness. Learn why researchers advo…
Oklahoma Senate Passes Ibogaine Clinical Trials Bill, Awaiting Governor’s Signature
The Oklahoma State Senate has passed House Bill 3834, authorizing state-funded ibogaine clinical trials for substance use and mental health disorders. Lea…
Georgia Governor Signs SB 220, Expanding Medical Cannabis Access and Revising Potency Limits
Georgia Governor Brian Kemp signed SB 220, expanding medical cannabis access by adding qualifying conditions, allowing vaping for patients over 21, and re…
Preliminary Research Explores *Inonotus hispidus* in Renal Cell Carcinoma Pathways
New research investigates the potential of *Inonotus hispidus* in modulating pathways associated with renal cell carcinoma. Learn about preliminary findin…
Hemp Fiber Market Projected to Reach US$46.80 Billion by 2033, Driven by Diverse Applications
A Coherent Market Insights study projects the global hemp fiber market to reach US$46.80 billion by 2033, growing at a 22.7% CAGR. Understand the key driv…
Massachusetts Lawmakers Decline Action on Cannabis Sales Rollback Initiative
Massachusetts lawmakers have opted not to act on a ballot initiative to repeal commercial recreational cannabis sales, leaving the measure to activists. U…
Kansas Silver Haired Legislature Continues Advocacy for Medical Cannabis Legalization
The Kansas Silver Haired Legislature (KSHL) continues its push for medical cannabis legalization, advocating for safe patient access and prescribing guida…
Bioxyne Secures A$50 Million Medicinal Cannabis Supply Agreement in German Market
Bioxyne (ASX:BXN) secures a A$50 million medicinal cannabis supply agreement with German firm ADREXpharma. This two-year deal expands its European market…
Employment Appeal Tribunal Refers Medical Cannabis Prescription Discrimination Case for Reconsideration
UK Employment Appeal Tribunal refers medical cannabis prescription discrimination case for review. Employers must navigate complexities of prescribed cann…
WholeLife Botanicals: An Integrated Approach to Patient-Centred Medicinal Cannabis Access
Explore how WholeLife Botanicals, rooted in community pharmacy, is enhancing patient-centred medicinal cannabis access in Australia. Learn about their int…
